RxDoctor Payments Data

Dara Shalom

Urogynecology and Reconstructive Pelvic Surgery · Great Neck, NYNPI 1245498518

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $65,349 of the $93,613 with a category attached, or 69.8%. Boston Scientific accounts for 85.8% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $39,026, more than ten times the $59 reported in 2019. Among urogynecology and reconstructive pelvic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$93,613in general payments, 2019–2025

Across 167 payments — averaging $560.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$80K
  • Femselect Inc.$7K
  • Axonics, Inc.$5K
  • Coloplast$384
  • Medtronic$24

What the payments were for

  • Consulting fees$11,50012%
  • Speaking & faculty fees$65,34970%
  • Travel & lodging$11,90613%
  • Food & beverage$4,8585%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific99$80,297
Femselect Inc.10$7,499
Axonics, Inc.42$5,408
Coloplast15$384
Medtronic1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$93,613 in reported general payments places this provider in the 95th percentile of 90 urogynecology and reconstructive pelvic surgery providers in New York.

See all urogynecology and reconstructive pelvic surgery providers in New York

Medicare billing

Part B allowed, 2024
$291,049
Medicare patients
798
Services billed
3,053

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron90$72,475
GemtesaVibegron87$53,674
Estradiol339$36,534
YuvafemEstradiol76$13,429
Mirabegron ErMirabegron23$11,367
EstringEstradiol12$6,261
PremarinEstrogens, Conjugated13$5,588
Solifenacin Succinate78$5,129
Methenamine Hippurate63$2,883
Trimethoprim16$1,550
NitrofurantoinNitrofurantoin Macrocrystal15$591
Clobetasol Propionate19$415
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst26$192
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim25$55

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Great Neck

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →